Purdue Center for Cancer Research (PCCR) Advisors

Director’s Advancement Board

They may not be raising awareness and securing funds, but their assistance and guidance are invaluable. This Director’s Advancement Board helps guide PCCR in raising awareness and securing funds — an important aspect of any research-based institution. They assist our director, Timothy Ratliff, and the executive committee set goals and identify opportunities for public, governmental and private fundraising.

Current Director’s Advancement Board Members

List of Current Director's Advancement Board Members
Ms. Beth Bangs West Lafayette, IN
Mr. Donald Dunaway Naples, FL
Mr. Todd Gilman Manhattan Beach, CA
Ms. Donna Heckler St. Louis, MO
Ms. Paula Klipsch Carmel, IN
Ms. Joy Matson Rossville, IN
Mr. Rick Miller Plymouth, IN
Ms. Martha (Marti) Schmidt Naperville, IL
Mr. Don Schoeff Huntington, IN
Mr. Alan Karpick West Lafayette, IN


List of Ambassador
Ms. Linda Rohrman Lafayette, IN

Drug Evaluation Committee

The overall goal of this committee is to help PCCR increase the number and quality of lead therapeutic molecules in development in the drug discovery pipeline at Purdue University, specifically those drugs with the potential to treat or prevent cancer.

Dr. John Landis

Dr. Gunda Georg

Dr. James S. MacDonald

Dr. Philip Hipskind

Dr. Homer Pearce

Dr. Ivan Horak

Dr. Catherine Strader

Dr. Arthur M. Krieg

Dr. Kalpana Merchant

Dr. Nicholas Meanwell

Dr. Franklyn G. Prendergast

External Advisory Committee

PCCR’s Advisory Committee is composed of outside authorities in cancer research. The expertise of these 14 scientists drives research initiatives in cancer drug discovery and evaluation, target validation, DNA damage-response mechanisms, toxicology, antitumor agent development, and engineering, among other areas. Their objective insights and guidance are integral to the continued progress of PCCR.

Dennis E. Discher, PhD
Robert D. Bent Professor
University of Pennsylvania

Edison T. Liu, MD
President and CEO
The Jackson Laboratory

Kim Lyerly, MD, FACS
George Barth Geller Professor of Cancer Research
Professor of Surgery
Associate Professor of Pathology/Assistant Professor of Immunology Duke University School of Medicine 

Jinming Gao, PhD
Professor of Biological Chemistry
Simmons Comprehensive Cancer Center/UT Southwestern Medical Center at Dallas

John Pezzuto, PhD
Professor and Dean, Arnold and Marie Schwartz College of Pharmacy and Health Sciences
Vice President, Long Island University Health and Research

Kit Lam, MD, PhD
Professor and Chair Department of Biochemistry and Molecular Medicine
Professor of Medicine Division of Hematology and Oncology
University of California Davis Cancer Center

Lisa Sideras
Associate Director
Cancer Center Administration
The Wistar Institute

Michael Ostrowski, PhD
W.H. Folk Chair in Experimental Oncology
Hollings Cancer Center
Medical University of South Carolina

Mark Walter, PhD (Chair)
Department of Microbiology/University of Alabama Birmingham

Nikola Pavletich, PhD
Chair, Structural Biology Program
Memorial Sloan Kettering Cancer Center

Peter Wipf, PhD
Director of the Combinatorial Chemistry Center and
The Center for Chemical Methodologies and Library Development
University of Pittsburgh Department of Chemistry/Chevron Science Center

Robert Lewis, PhD
Eppley Institute for Research in Cancer and Allied Diseases
University of Nebraska Medical Center

Steven K. Clinton, MD, PhD
Professor, Internal Medicine
Ohio State University (Comprehensive Cancer Center)

Susan Mooberry, PhD
Professor of Pharmacology
Co-Leader of Experimental and Developmental Therapeutics, CTRC at UTHSCSA
UT Health Science Center San Antonio